ENTITY
Kolon TissueGene

Kolon TissueGene (950160 KS)

16
Analysis
Health Care • United States
Kolon TissueGene, Inc. operates as a biopharmaceutical company. The Company develops novel advanced orthopedic disorders cell therapies, novel cell and gene therapies drugs, and other related products. Kolon TissueGene offers services worldwide.
more
•21 Sep 2017 19:58

TissueGene IPO Part 1 - IPO Prospectus Summary

What is Korea's hottest stock now? I guess many investors will have SillaJen, Inc. (0908477D KS) in their mind when asked this question. SillaJen's...

Logo
871 Views
Share
x